Results 31 to 40 of about 26,354 (184)

Survival After Combining Stereotactic Body Radiation Therapy and Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma

Frontiers in Oncology, 2021
BackgroundStereotactic body radiation therapy (SBRT) and tyrosine kinase inhibitors (TKIs) are effective treatments for metastatic renal cell carcinoma, but data on combining these two modalities are scarce.
Yang Liu, Zhiling Zhang, Hui Han, Shengjie Guo, Zhuowei Liu, Mengzhong Liu, Fangjian Zhou, Pei Dong, Liru He   +8 more
doaj   +1 more source

Supplementary Material for: Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-alone in Unresectable Hepatocellular Carcinoma (HCC)

, 2023
Introduction While combination of stereotactic body radiotherapy (SBRT) and immunotherapy are promising, their efficacy and safety have not been compared with SBRT-alone in patients with unresectable HCC.
Chan K.S.K. (17075689), Chiang C.L. (17075683), Kong F.-M.S. (17075719), Chan A.C.Y. (17075722), Kwan M. (17075716), Yeung C.S.Y. (17075710), Yip W.W.L. (17075707), Fong J.K.S. (17075701), Wong N.S.M. (17075704), Chiu K.W.H. (17075695), Lee V.W.Y. (17075692), Ho R.L.M. (17075698), Lau V.W.H. (17075713), Lee F.A.S. (17075686)   +13 more
core   +1 more source

The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors

Journal of Cardiothoracic Surgery, 2020
Background Stereotactic body radiation therapy (SBRT) has recently been widely performed for relatively small-volume tumors. We analyzed the short-term outcomes of pulmonary metastasectomy (PM) or SBRT for pulmonary metastases.
Ryu Kanzaki, Osamu Suzuki, Takashi Kanou, Naoko Ose, Soichiro Funaki, Yasushi Shintani, Masato Minami, Keisuke Tamari, Keisuke Otani, Yuji Seo, Fumiaki Isohashi, Kazuhiko Ogawa, Meinoshin Okumura   +12 more
doaj   +1 more source

The Role of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients: A Literature Review

Indonesian Journal of Cancer
Background: Globally, hepatocellular carcinoma (HCC) is the most prevalent kind of primary liver cancer. Treatment options for HCC include radiotherapy, immunotherapy, surgery, targeted therapy, transarterial chemoembolization, and hepatic arterial ...
Angela Giselvania, Sri Mutya Sekarutami, Arie Munandar, Devina Adella Halim, Felix Wijovi   +4 more
doaj   +1 more source

Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy

The Korean Journal of Gastroenterology, 2022
Purpose: To investigate the prognostic value of the neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in patients with hepatocellular carcinoma (HCC) treated with stereotactic body radiotherapy (SBRT).
Younghee Park, Ah Ram Chang
doaj   +1 more source

Dosimetric study for spine stereotactic body radiation therapy: magnetic resonance guided linear accelerator versus volumetric modulated arc therapy

Radiology and Oncology, 2019
Stereotactic body radiation therapy (SBRT) given in 1-5 fractions is an effective treatment for vertebral metastases. Real-time magnetic resonance-guided radiotherapy (MRgRT) improves soft tissue contrast, which translates into accurate delivery of spine
Yadav Poonam, Musunuru Hima B., Witt Jacob S., Bassetti Michael, Bayouth John, Baschnagel Andrew M.   +5 more
doaj   +1 more source

SBRT for centrally localized NSCLC - What is too central? [PDF]

, 2016
Purpose Current guidelines recommend stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer (NSCLC) in medically inoperable patients. There are excellent outcome and toxicity data for SBRT of peripheral lung tumors.
N. Andratschke, Panje, C, Mantel, F., M. Guckenberger, Nestle, Ursula, Guckenberger, Matthias, Panje, C., J. Roesch, Guckenberger, M, Nestle, U., Mantel, F, C. Panje, Roesch, Johannes, Andratschke, N, Guckenberger, M., Roesch, J, Andratschke, N., Sterzing, F, Andratschke, Nicolaus, U. Nestle, Sterzing, F., F. Sterzing, F. Mantel, Sterzing, Florian, Roesch, J., Nestle, U   +25 more
core   +1 more source

Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy

EBioMedicine, 2020
Background: Stereotactic body radiotherapy (SBRT) is an effective treatment for hepatocellular carcinoma (HCC). This study sought to identify differentially expressed plasma metabolites in HCC patients at baseline and early during SBRT, and to explore if
Sylvia S.W. Ng, Gun Ho Jang, Irwin J. Kurland, Yunping Qiu, Chandan Guha, Laura A. Dawson   +5 more
doaj   +1 more source

Comparative effectiveness of stereotactic body radiation therapy versus surgery for stage I lung cancer in otherwise healthy patients: An instrumental variable analysisCentral MessagePerspective

JTCVS Open, 2022
Objectives: Stereotactic body radiation therapy (SBRT) is an established primary treatment modality in patients with lung cancer who have multiple comorbidities and/or advanced-stage disease.
Michael J. Littau, BA, Richard Freeman, MD, MBA, Wickii T. Vigneswaran, MD, MBA, Fred A. Luchette, MD, MSc, Marshall S. Baker, MD, MBA, Wissam Raad, MD, Zaid M. Abdelsattar, MD, MSc, Tyler Grenda, MD, MS, James Lubawski, MD, Maria Lucia L. Madariaga, MD   +9 more
doaj   +1 more source

Hypervision Proton Surgery: The Future Direction of Proton Therapy

iNew Medicine, EarlyView.
ABSTRACT Proton beams provide unique physical advantages characterized by a low entrance dose, negligible exit dose, and a sharp Bragg peak, which enable superior sparing of normal tissues and support safe dose escalation for improved tumor control. However, conventional photon‐based fractionation remains widely used in proton therapy, where prolonged ...
Li Li, Shuanghu Yuan
wiley   +1 more source